A cohort study examining the risk of hepatitis B virus (HBV) reactivation in people living with HIV after switching to antiretroviral drugs (ARVs) that do not offer dual protection found that the overall risk was low, even among hepatitis B core Antibody-positive patients.
Rachel V. Denyer, MD, FRCP, of the Veterans Affairs Medical Center in Washington, D.C., and George Washington University, presented at the IDWeek 2023 conference, held in Boston, Massachusetts, October 11-14. One result.
However, new antiretroviral drugs introduced in the past decade, including dolutegravir-rilpivirine and the long-acting injectable cabotegravir-rilpivirine, are becoming the treatments of choice for people living with HIV; Discontinuation of medications such as norfovir, including nucleos
Publishers Mindscape Developers P.F. Magic Release date 1998 Genre Simulation Game rating Description of the…
Editors Activision, Inc. Developers superego games Release date 2006 Gender Adventure Game Rating Game Description…
Editors Terraglyph Interactive Studios, Warner Bros. Interactive Entertainment. Developers Terraglifo interactive studios Release date nineteen…
Editors Sega, Digital Images, Screaming Villains, Limited Run Games Developers Digital Images, Inc. Release date…
Editors Davilex Games BV Developers Davilex Games BV Release date 1998 Gender Careers Game Rating…
Editors Sony Computer Entertainment, Disney Interactive Studios Developers High voltage software Release date 2002 Gender…